Middle East & Africa Topical Drugs Market Size & Outlook

The topical drugs market in Middle East & Africa is expected to reach a projected revenue of US$ 5,304.7 million by 2030. A compound annual growth rate of 4.2% is expected of Middle East & Africa topical drugs market from 2025 to 2030.
Revenue, 2024 (US$M)
$4,194.9
Forecast, 2030 (US$M)
$5,304.7
CAGR, 2025 - 2030
4.2%
Report Coverage
Middle East & Africa

MEA topical drugs market highlights

  • The MEA topical drugs market generated a revenue of USD 3,438.9 million in 2021.
  • The market is expected to grow at a CAGR of 7.7% from 2022 to 2030.
  • In terms of segment, dermal drug delivery was the largest revenue generating route of administration in 2021.
  • Dermal Drug Delivery is the most lucrative route of administration segment registering the fastest growth during the forecast period.
  • Country-wise, UAE is expected to register the highest CAGR from 2022 to 2030.


MEA data book summary

Market revenue in 2021USD 3,438.9 million
Market revenue in 2030USD 6,708.0 million
Growth rate7.7% (CAGR from 2021 to 2030)
Largest segmentDermal drug delivery
Fastest growing segmentDermal Drug Delivery
Historical data covered2018 - 2020
Base year for estimation2021
Forecast period covered2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery
Key market players worldwideBayer AG, Cipla Ltd DR, GSK PLC ADR, Johnson & Johnson, Novartis AG ADR, Bausch Health Companies Inc, Hisamitsu Pharmaceutical Co Inc, Merck & Co Inc, Glenmark Pharmaceuticals, MedPharm


Other key industry trends

  • In terms of revenue, MEA region accounted for 3.1% of the global topical drugs market in 2021.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • North America is the fastest growing regional market and is projected to reach USD 87,879.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Topical Drugs Market Companies

Name Profile # Employees HQ Website

Middle East & Africa topical drugs market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to topical drugs market will help companies and investors design strategic landscapes.


Dermal drug delivery was the largest segment with a revenue share of 53.71% in 2024. Horizon Databook has segmented the Middle East & Africa topical drugs market based on dermal drug delivery, ophthalmic drug delivery, rectal drug delivery, vaginal drug delivery, nasal drug delivery covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Middle East & Africa topical drugs market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa topical drugs market databook

  • Our clientele includes a mix of topical drugs market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa topical drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa topical drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA topical drugs market report size, by country, 2018-2030 (US$M)

Middle East & Africa Topical Drugs Market Outlook Share, 2024 & 2030 (US$M)

MEA topical drugs market report size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more